GlobeNewswire 01-08 Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its ...
GlobeNewswire 01-07 Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...
GlobeNewswire 01-04 Stran & Company Appoints Ian Thomas Wall as Chief Information Officer
GlobeNewswire 01-04 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 2023-12-19 Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European C...
GlobeNewswire 2023-12-15 CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Fri...
GlobeNewswire 2023-12-14 ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is...
GlobeNewswire 2023-12-13 U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Scler...
GlobeNewswire 2023-12-12 Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support F...
GlobeNewswire 2023-12-11 BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
GlobeNewswire 2023-12-04 TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as ...
GlobeNewswire 2023-11-28 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...
GlobeNewswire 2023-11-27 Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
TeleTrader 2023-11-09 Dow, S&P 500 turn green in premarket trade
TeleTrader 2023-11-08 Biogen's Q3 revenue up 3% to $2.5B
GlobeNewswire 2023-11-08 Royalty Pharma Reports Third Quarter 2023 Results
TeleTrader 2023-11-08 US slightly down premarket, earnings in focus
GlobeNewswire 2023-11-07 Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
GlobeNewswire 2023-11-07 US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spher...
GlobeNewswire 2023-11-06 Biogen Appoints Monish Patolawala to its Board of Directors
GlobeNewswire 2023-11-03 Editas Medicine Announces Third Quarter 2023 Results and Business Updates
GlobeNewswire 2023-11-01 Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
GlobeNewswire 2023-11-01 C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
GlobeNewswire 2023-10-25 Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study ...
GlobeNewswire 2023-10-25 New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise f...